Observational studyCurrent oncology (Toronto, Ont.)2026
Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab-Lenvatinib: A Retrospective Real-World Study.
Eleonora Palluzzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.